本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Taro Pharmaceutical Industries L

42.97
+0.0000
成交量:- -
成交额:- -
市值:16.15亿
市盈率:29.98
高:42.97
开:42.97
低:42.97
收:42.97
数据加载中...
2020/06/19

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/05/15

SEC问询函

CORRESP [Cover] - Correspondence
2020/04/10

SEC问询函

CORRESP [Cover] - Correspondence
2020/04/06

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/21

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/20

SEC问询函

CORRESP [Cover] - Correspondence
2020/02/07

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/04

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/10

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/30

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/23

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/23

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/17

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/06

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/03

SEC问询函

[Cover]Correspondence
2019/11/15

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/06

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/04

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/08/08

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/06/21

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]